Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | DHFR | P00374 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4361085 | 0.82 | HSD17B10 (0.48) | HSD17B10PIK3CGPIK3CAPIK3CBHDAC6 | |
| SCHEMBL25899100 | 0.77 | HSD17B10 (0.39) | HSD17B10PIK3CGPIK3CAPIK3CBHDAC6 | |
| SCHEMBL24629319 | 0.74 | PIK3CG (0.42) | PIK3CGPIK3CAPIK3CBHDAC6DHFR | |
| SCHEMBL9201051 | 0.74 | HSD17B10 (0.38) | HSD17B10PIK3CGPIK3CAPIK3CBHDAC6 | |
| SCHEMBL13314521 | 0.74 | HSD17B10 (0.69) | HSD17B10 | |
| SCHEMBL30287655 | 0.74 | HSD17B10 (0.69) | HSD17B10 | |
| SCHEMBL59520 | 0.74 | HSD17B10 (0.69) | HSD17B10 | |
| SCHEMBL59519 | 0.74 | HSD17B10 (0.69) | HSD17B10 | |
| SCHEMBL4542003 | 0.74 | HSD17B10 (0.69) | HSD17B10 | |
| SCHEMBL29776903 | 0.74 | HSD17B10 (0.69) | HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105228521-A | The new diagnostic method of diagnosis depression and monitor treatment effect | BRAINLABS B V | 2016-01-06 | — | — | CN | claimed |
| CN-1795010-A | Humanized antibodies to interferon alpha receptor-1 (ifnar-1) | MEDAREX INC (US) | 2006-06-28 | — | — | CN | claimed |
| JP-56099484-A | — | — | None | — | — | JP | disclosed |
| CN-103620058-B | Automated circulating tumor cell detection | 西门子公司 | 2017-04-12 | — | — | CN | disclosed |
| CN-106461654-A | Method for transferring beads | 斯潘奇普诊断公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-106461653-A | Method of separating beads in a fluidic chip | 斯潘奇普诊断公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-104302408-B | XTEN conjugate compositions and methods of making the same | 阿穆尼克斯运营公司 | 2016-12-14 | — | — | CN | disclosed |
| CN-105722518-A | Treatment of brain cancer with oncolytic adenovirus | 德那翠丝有限公司 | 2016-06-29 | — | — | CN | disclosed |
| CN-105435223-A | Methods of treating chronic inflammatory diseases using a GM-CSF antagonist | KALOBIOS PHARMACEUTICALS INC | 2016-03-30 | — | — | CN | disclosed |
| CN-105228521-A | The new diagnostic method of diagnosis depression and monitor treatment effect | BRAINLABS B V | 2016-01-06 | — | — | CN | disclosed |
| CN-105007933-A | Selective Nox1 inhibitor peptides and uses thereof | UNIV BORDEAUX | 2015-10-28 | — | — | CN | disclosed |
| CN-1177581-C | Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols | ���ָ��Ӣ��ķ�������Ϲ�˾ | 2004-12-01 | — | — | CN | disclosed |
| CN-1457258-A | Methods of treating viral diseases with IL-18 and IL-18 compositions | SMITHKLINE BEECHAM CORP (US) | 2003-11-19 | — | — | CN | disclosed |
| CN-1441677-A | Combination of anti-cytokine antibodies or antagonists with anti-CD 20 for treatment of B cell lymphomas | IDEC PHARMA CORP (US) | 2003-09-10 | — | — | CN | disclosed |
| CN-1299285-A | Recombinant human interferon beta-1A (IFN-beta-1A) formulation | BIOGEN INC (US) | 2001-06-13 | — | — | CN | disclosed |
| CN-1282255-A | IFNAR2/1FN complex | APPLIED RESEARCH SYSTEMS (NL) | 2001-01-31 | — | — | CN | disclosed |
| CN-1265583-A | Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols | BOEHRINGER INGELHEIM PHARMA (DE) | 2000-09-06 | — | — | CN | disclosed |
| CN-1245434-A | Stable liquid interferon formulations | BIOGEN INC (US) | 2000-02-23 | — | — | CN | disclosed |
| CN-1216470-A | Dehydroepiandrosterone combination therapy | PRENDERGAST PATRICK T (IE) | 1999-05-12 | — | — | CN | disclosed |
| JP-S5699484-A | PTERIN DERIVATIVE AND DETERMINATION OF PTERINS | DAIICHI RAJIO ISOTOPE KENKYUSHO:KK | 1981-08-10 | — | — | JP | disclosed |